In addition, for tumor types with IFN deficiency, some specific defects in the IFN signaling cascade can be used as potential biomarkers, which may help identify such individual cancer patients and obtain personalized treatment (16). The gene discussed is IFNA1; the disease is hyperinsulinemic hypoglycemia, familial, 4.